NO20084625L - Renininhibitorer for behandlingen av hypertensjon - Google Patents

Renininhibitorer for behandlingen av hypertensjon

Info

Publication number
NO20084625L
NO20084625L NO20084625A NO20084625A NO20084625L NO 20084625 L NO20084625 L NO 20084625L NO 20084625 A NO20084625 A NO 20084625A NO 20084625 A NO20084625 A NO 20084625A NO 20084625 L NO20084625 L NO 20084625L
Authority
NO
Norway
Prior art keywords
hypertension
treatment
renin inhibitors
methods
preventing
Prior art date
Application number
NO20084625A
Other languages
English (en)
Inventor
Andrew Satlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38420678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084625(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20084625L publication Critical patent/NO20084625L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen er relatert til metoder for forebyggingen av, forsinke progresjonen til eller behandlingen av hypertensjon, omfattende å administrere til et varmblodig dyr en terapeutisk effektiv mengde av en renin inhibitor eller et farmasøytisk akseptabelt salt derav så vel som metoder for å forebygge sekundære komplikasjoner forbundet til opphør av behandlingen av hypertensjon.
NO20084625A 2006-04-03 2008-11-03 Renininhibitorer for behandlingen av hypertensjon NO20084625L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78884206P 2006-04-03 2006-04-03
PCT/US2007/065564 WO2007118023A1 (en) 2006-04-03 2007-03-30 Renin inhibitors for the treatment of hypertension

Publications (1)

Publication Number Publication Date
NO20084625L true NO20084625L (no) 2008-11-03

Family

ID=38420678

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084625A NO20084625L (no) 2006-04-03 2008-11-03 Renininhibitorer for behandlingen av hypertensjon

Country Status (20)

Country Link
US (1) US20090062395A1 (no)
EP (1) EP2004167A1 (no)
JP (1) JP2009532494A (no)
KR (1) KR20080108515A (no)
CN (1) CN101415413A (no)
AU (1) AU2007234917B2 (no)
BR (1) BRPI0710095A2 (no)
CA (1) CA2645260A1 (no)
CL (1) CL2007000912A1 (no)
IL (1) IL193905A0 (no)
MA (1) MA30387B1 (no)
MX (1) MX2008012729A (no)
NO (1) NO20084625L (no)
NZ (1) NZ571251A (no)
RU (1) RU2008143055A (no)
SG (1) SG170830A1 (no)
TN (1) TNSN08383A1 (no)
TW (1) TW200806283A (no)
WO (1) WO2007118023A1 (no)
ZA (1) ZA200807615B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087116A1 (en) * 2008-01-11 2009-07-16 Novartis Ag Use of spp100 for the treatment of acute mi
CN102212012A (zh) * 2010-04-12 2011-10-12 上海源力生物技术有限公司 一种合成阿利克伦的中间体及其制备方法
WO2013057313A1 (en) 2011-10-20 2013-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the detection and the treatment of cardiac remodeling
CA3137138A1 (en) * 2019-04-18 2020-10-22 EyePoint Pharmaceuticals, Inc. Methods of treating hypertension with activators of tie-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
CA2490811A1 (en) * 2002-06-28 2004-01-08 Novartis Ag Use of organic compounds
WO2004100871A2 (en) * 2003-05-09 2004-11-25 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
PE20142101A1 (es) * 2004-03-17 2014-12-27 Novartis Ag Composiciones farmaceuticas de aliskiren
CA2581927C (en) * 2004-09-27 2013-04-09 Pantarhei Bioscience B.V. Treatment or prevention of unscheduled bleeding in women on progestogen containing medication

Also Published As

Publication number Publication date
BRPI0710095A2 (pt) 2011-08-02
JP2009532494A (ja) 2009-09-10
TNSN08383A1 (en) 2009-12-29
CN101415413A (zh) 2009-04-22
TW200806283A (en) 2008-02-01
AU2007234917A1 (en) 2007-10-18
MX2008012729A (es) 2008-10-14
AU2007234917B2 (en) 2011-05-12
MA30387B1 (fr) 2009-05-04
IL193905A0 (en) 2009-08-03
CA2645260A1 (en) 2007-10-18
CL2007000912A1 (es) 2008-03-14
NZ571251A (en) 2011-12-22
SG170830A1 (en) 2011-05-30
KR20080108515A (ko) 2008-12-15
US20090062395A1 (en) 2009-03-05
ZA200807615B (en) 2009-10-28
WO2007118023A1 (en) 2007-10-18
EP2004167A1 (en) 2008-12-24
RU2008143055A (ru) 2010-05-10

Similar Documents

Publication Publication Date Title
EA200970856A1 (ru) Ингибиторы пути хеджхога
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
UA95955C2 (ru) Ингибиторы обратной транскриптазы вич
EA201390428A1 (ru) Композиции и способы лечения легочной гипертензии
WO2008049000A3 (en) Combination therapy for pulmonary arterial hypertension
WO2007101232A3 (en) Inhibition of jak2 as a treatment of pulmonary arterial hypertension
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
EA201070786A1 (ru) Бензофуропиримидиноны
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
NO20070917L (no) Imidazotriaziner som protein-kinaseinhibitorer
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
UA94129C2 (ru) Соединения для ингибирования митоза
MX2009004984A (es) Metodos para conservar la funcion renal utilizando inhibidores de oxidoreductasa de xantina.
GEP20125708B (en) Hydroxamate-based inhibitors of deacetylases b
EA201070442A1 (ru) НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ
IN2012DN01273A (no)
WO2008030795A3 (en) Compositions and methods for inhibition of tyrosine kinases
WO2007140317A3 (en) Use of inhibitors of cytosolic ph0sph0lipase a2 in the treatment of thrombosis
NO20084625L (no) Renininhibitorer for behandlingen av hypertensjon
EA200970164A1 (ru) Ингибиторы каспазы на основе пиридазинонового каркаса
WO2007019153A3 (en) Methods for treating hypertension
EP2248520A3 (en) Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure
WO2009148600A8 (en) Deuterated lysine-based compounds
DK1791537T3 (da) 3-arylthioindol-2-carboxamidderivater og analoger deraf som inhibitorer af casein-kinase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application